SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-022677
Filing Date
2023-06-20
Accepted
2023-06-20 16:00:27
Documents
13
Period of Report
2023-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20230615.htm   iXBRL 8-K 55065
2 EX-10.1 chromadexcorporationamende.htm EX-10.1 217539
  Complete submission text file 0001628280-23-022677.txt   439483

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20230615.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20230615_lab.xml EX-101.LAB 23894
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20230615_pre.xml EX-101.PRE 12519
7 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20230615_htm.xml XML 4124
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 231024934
SIC: 2833 Medicinal Chemicals & Botanical Products